How to Buy Cullinan Therapeutics Stock

Cullinan Therapeutics Inc

Cullinan Oncology Inc. , a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States.

Cullinan Therapeutics stock last closed at $8.61, down 3.8% from the previous day, and has decreased 60.5% in one year. It has overperformed other stocks in the Biotechnology industry by 0.16 percentage points. Cullinan Therapeutics stock is currently +25.69% from its 52-week low of $6.85, and -59.02% from its 52-week high of $21.01.

As of Jun 13, 2025, there are 59.01M CGEM shares outstanding. The market capitalization of CGEM is $508.12M. In the last 24 hours, 264,000 CGEM shares were traded.

How to Buy Cullinan Therapeutics Stock

Wondering how to invest in Cullinan Therapeutics stock? Here's how.

  1. Decide where to buy Cullinan Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you figure out where to buy Cullinan Therapeutics stock.
  2. Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
  3. Put funds into your investment account: Choose your payment method and add your info.
  4. Research Cullinan Therapeutics stock: The Cullinan Therapeutics ticker symbol is CGEM. Is Cullinan Therapeutics stock a good investment? Should you buy shares of CGEM? How do CGEM's underlying business fundamentals look? Do top analysts think Cullinan Therapeutics is a good buy? Why has CGEM's stock price moved recently? (Hint: Our stock market research tools can help you decide if CGEM is a good stock to buy).
  5. Execute your CGEM trade: Decide if you will purchase CGEM shares at the current market price or use a limit order to buy CGEM stock at a given price.
  6. Watch your investment in CGEM: Create a watchlist to key updates about your new investment in Cullinan Therapeutics stock.

Step 1: Decide where to buy Cullinan Therapeutics stock

You need a brokerage account to access the NASDAQ market and buy CGEM stock.

A brokerage account allows you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our research, eToro is the best online stock brokerage. Here's why:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
  • Access to world markets: From Technology to Real Estate, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
  • Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've selected the best brokerage, you need to fill out some personal info so you can buy CGEM today.

How to Create a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to open a new trading account.
  1. Send your data by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your investment account

Now that you've created your account on apps for stocks, your next step is to transfer the money for your investment:

Check out the tutorial below to see the process of transferring money into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Cullinan Therapeutics stock

After you have selected the best place to buy Cullinan Therapeutics stock, it's very important to analyze their stock prior to investing, so you truly understand the risk and opportunity.

Cullinan Therapeutics shares quick numbers

CGEM Price
$8.61
1w %
-5.18%
1y %
-60.5%
5y %
N/A
P/E
-3.24x
P/B
0.92x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$180.07M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$508.12M
Next Earnings
N/A
Next Dividend
N/A

Cullinan Therapeutics Overview

WallStreetZen was built to help average investors perform better fundamental analysis in minutes instead of hours.

You can view all of the due diligence checks on CGEM's stock page.

Is CGEM stock undervalued or overvalued?

You can use many financial metrics, analyses, models, and charts to gauge CGEM's intrinsic value.

Using relative valuations measures:

  • CGEM may be undervalued based on its P/B ratio of 0.92x, relative to Biotechnology industry P/B ratio of 4.66x

You can access more valuation research on CGEM's stock here.

CGEM Financial Health Summary

Pros:

  • There are more short-term assets than long-term liabilities on the CGEM balance sheet.
  • There are more short-term assets than short-term liabilities on the CGEM balance sheet.
  • CGEM has cash burn of 150211000. It has enough cash and short-term investments to cover this for at least one year.
  • CGEM has a low debt to equity ratio of 0.05.

Cons:

  • CGEM has $303.83M in cash and short term investments. This is not sufficient to cover its annual cash burn of $150.21M.

Is it a good time to buy Cullinan Therapeutics stock, according to Wall Street analysts?

Out of 4 sell side analysts who track CGEM, the consensus analyst rating on CGEM is a Strong Buy

It's important to note that analyst forecasts are not recommendations, nor are they financial advice.

You can dig deeper into what analysts are saying on the Cullinan Therapeutics stock forecast page.

CGEM Technicals

SMA10
8.89
SMA20
8.43
SMA50
8.07
SMA100
8.62
SMA200
11.71
MACD
0.26
MACD Signal
0.23
MACD Histogram
0.03
RSI
52.96
Stochastic %K
69.99
Stochastic %D
75.15
StochRSI %K
46.12
StochRSI %D
55.36

Is CGEM Growing Revenue?

Last year, CGEM revenue was $0.00. In the last four year, CGEM's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 43.24%.

Dive into CGEM's earnings and revenue performance here.

Latest Insiders Trades at CGEM

Over the last year, insiders at CGEM have sold more shares than they have bought.

Nadim Ahmed, President and CEO of CGEM, was the latest CGEM insider to sell. They sold $106,872.37 worth of CGEM stock on Feb 25, 2025.

Learn more about who owns CGEM shares here.

Does CGEM provide a stable income stream?

No, Cullinan Therapeutics doesn't provide an income stream by paying out dividends.

What do other investors have to say about CGEM?

One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Execute your CGEM trade

There are two main order types:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are generally the easiest way to buy.
  • Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
    If you want to make sure you're buying or selling at an exact price, use a limit order.

Click the Open button and eToro will place the order.

If you want more info about buying stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Watch your investment in CGEM

Now that you own some CGEM stock, you'll want to keep up with your new shares.

Put CGEM on a watchlist to keep track of your CGEM stock.

CGEM Feed

How to Buy Stock in Cullinan Therapeutics

To summarize, here are the 6 steps to buy stock in Cullinan Therapeutics:

  1. Decide where to buy Cullinan Therapeutics stock
  2. Create a brokerage account
  3. Put funds into your investment account
  4. Research Cullinan Therapeutics stock
  5. Execute your CGEM trade
  6. Watch your investment in CGEM

If you are looking for a place to buy stocks, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to keep track of your new investment in Cullinan Therapeutics, add CGEM to your watchlist by clicking the button below.

NASDAQ: CGEM
$8.61-0.34 (-3.8%)
Updated Jun 13, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: CGEM
$8.61-0.34 (-3.8%)
Updated Jun 13, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Cullinan Therapeutics share?

As of Jun 13, 2025, it costs $8.61 to buy one share of Cullinan Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $4, you can buy 0.465 shares of CGEM.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Cullinan Therapeutics stock?

According to 4 Wall Street analysts who monitor Cullinan Therapeutics, their consensus recommendation is to buy Cullinan Therapeutics stock.

What is the best way to buy Cullinan Therapeutics stock?

One way to place an order for Cullinan Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.